A nationwide recall has been issued for ReBoost Nasal Spray due to potential health risks. The Food and Drug Administration (FDA) and the Hawaii Department of Health have announced the recall, warning consumers of the presence of yeast, mold, and microbial contamination in the product. This contamination poses a serious threat to the health of immunocompromised individuals, who may face life-threatening infections upon use.
The affected product can be identified by the following details: NDC number 62795-4005-9, UPC number 787647101863, lot number 224268, and expiration date of December 2027. The nasal spray was distributed across the country, but the specific stores where it was sold are yet to be disclosed. The Hawaii Department of Health is working with the FDA to ensure the product is no longer available for purchase in the state.
If you have purchased or used the recalled ReBoost Nasal Spray, it is crucial to take immediate action. Discontinue use and return the product to your place of purchase for a refund. If you have experienced any unexplained symptoms, such as fever, swollen sinuses, headaches, face pain or pressure, facial numbness, or are immunocompromised, seek medical attention promptly. The FDA encourages reporting any adverse reactions to the product through their MedWatch program, as no reports have been received so far, despite the potential risks.
This recall is part of a growing concern in the healthcare industry, with recent recalls including faulty chargers that may catch fire and shredded cheese with possible metal fragments. It highlights the importance of vigilance and prompt action when it comes to product safety, especially for vulnerable populations.
